Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SGI-1776 (Pim-Kinase Inhibitor IX) 是一种Pim 抑制剂,抑制 Pim-1、Pim-2 和 Pim-3 的活性,IC50值分别为 7 nM、363 nM 和 69 nM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 267 | 现货 | ||
5 mg | ¥ 867 | 现货 | ||
10 mg | ¥ 1,676 | 现货 | ||
25 mg | ¥ 2,815 | 现货 | ||
50 mg | ¥ 3,440 | 现货 | ||
100 mg | ¥ 4,990 | 现货 | ||
500 mg | ¥ 10,500 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 954 | 现货 |
产品描述 | SGI-1776 (Pim-Kinase Inhibitor IX) has been used in trials studying the treatment of Prostate Cancer, Non-Hodgkins Lymphoma, and Relapsed/Refractory Leukemias. |
靶点活性 | FLT3:44 nM, Pim1:7 nM, Pim3:69 nM, Pim2:363 nM |
体外活性 | SGI-1776已经显示出针对白血病和实体瘤细胞系模型的临床前活性,其IC50值为0.005-11.68 mM.在31个实体瘤异种移植物中的9个和8个可评估的ALL异种移植物中的1个中,SGI-1776诱导体内EFS分布的显著差异.SGI-1776对携带MV-4-11肿瘤的小鼠模型有效. |
体内活性 | SGI-1776诱导CLL细胞剂量依赖性凋亡。SGI-1776诱导CLL细胞凋亡,作用机理涉及Mcl-1减少。SGI-1776在体外,具有毒性,且平均相对IC50值为3.1 mM。SGI-1776除了Pim, 也有效靶向作用于FLT3 ,IC50 = 44 nM。SGI-1776诱导AML细胞凋亡,这种作用存在浓度依赖性。SGI-1776 作用于AML原代细胞,具有毒性,且导致Mcl-1蛋白降低。 |
激酶实验 | Kinase Assays: Kinase inhibition is measured by the use of radiometric assays performed by KinaseProfiler service. Assays contain a peptide substrate, known purified recombinant human kinases, gamma-labeled ATP, magnesium ion, and a fixed concentration (1 μM) of SGI-1776. In a final reaction volume of 25 μL, 5 to 10 mU of Pim1/2/3 is incubated with 8 mM of MOPS, pH 7.0; 0.2 mM ethylene diamine tetraacetic acid; 100 μM KKRNRTLTV;10 mM MgAcetate; and [γ-32P-ATP] . The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 5 μL of a 3% phosphoric acid solution. Then, 10 μL of the reaction is spotted onto a P30 filtermat and washed 3 times for 5 minutes in 75 mM phosphoric acid and once in methanol before it is dried and measured via a scintillation counter. |
细胞实验 | Cells are cultured in IMDM (ATCC) supplemented with 10% FBS and grown in a 37oC incubator with 5% CO2. Cells are routinely tested for Mycoplasma infection using a commercially available kit. Cells are treated with DMSO or various concentrations of SGI-1776 for 24 hours. Cells (1×106) are washed, then resuspended in 100 μL of annexin binding buffer, mixed with 5 μL of FITC solution and 5 μL of propidium iodide (PI; 50 μg/mL) solution. For each sample, 1×104 cells are measured using a Becton Dickinson FACSCalibur flow cytometer. (Only for Reference) |
别名 | SGI-1776 free base, Pim-Kinase Inhibitor IX |
分子量 | 405.42 |
分子式 | C20H22F3N5O |
CAS No. | 1025065-69-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 75 mg/mL (185 mM)
Ethanol: 75 mg/mL (185 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO / Ethanol | 1 mM | 2.4666 mL | 12.3329 mL | 24.6658 mL | 61.6644 mL |
5 mM | 0.4933 mL | 2.4666 mL | 4.9332 mL | 12.3329 mL | |
10 mM | 0.2467 mL | 1.2333 mL | 2.4666 mL | 6.1664 mL | |
20 mM | 0.1233 mL | 0.6166 mL | 1.2333 mL | 3.0832 mL | |
50 mM | 0.0493 mL | 0.2467 mL | 0.4933 mL | 1.2333 mL | |
100 mM | 0.0247 mL | 0.1233 mL | 0.2467 mL | 0.6166 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
SGI-1776 1025065-69-3 Angiogenesis Apoptosis Autophagy Chromatin/Epigenetic JAK/STAT signaling Tyrosine Kinase/Adaptors Pim FLT Inhibitor SGI 1776 Pim kinases SGI-1776 free base SGI1776 inhibit Pim-Kinase Inhibitor IX inhibitor